Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2025 Earnings Call Transcript

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2025 Earnings Call Transcript May 2, 2025

Operator: Thank you for standing by. Hello and welcome to the Summit Therapeutics Q1 2025 Earnings Conference Call. I would now like to turn the call over to our Chief Business and Strategy Officer, Dave Gancarz. Please go ahead, sir.

Dave Gancarz: Good afternoon and thank you for joining us. A press release was issued earlier this afternoon and is available on the homepage of our website. Our Form 10-Q was...